References
- International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594–603.
- Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre Syndrome. Arch Neurol 2001; 58: 913–7
- Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005; 366: 1653–66
- Antoine J-C, Mosnier J-F, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 76: 7–14
- Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. NEJM 1999; 340: 1788–95
- de Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, ten Bokkel Huinink WW, et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 1997; 15: 1837–43
- Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup-C. Neuronal involvement in cisplatin neuropathy: Prospective clinical and neurophysiological studies. Brain 2007; 130: 1076–88
- Vigliani MC, Magistrello M, Polo P, Mutani R, Chio A. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol 2004; 251: 321–6
- Tho LM, O'Leary CP, Horrocks I, Al-Ani A, Reeds NS. Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer. Gynecol Oncol 2006; 100: 615–7
- Christodoulou C, Anastasopoulos D, Visvikis A, Mella S, Detski I, Tsiakalos G, et al. Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anti-Cancer Drugs 2004; 15: 997–9